South Korea Hemostats Market Size, Share, and COVID-19 Impact Analysis, By Type (Oxidized Regenerated Cellulose Based Hemostats and Combination Haemostats), By Formulation (Matrix & Gel Hemostats and Sponge Hemostats), By Application (Orthopedic Surgery and Cardiovascular Surgery), By End-use (Hospital & Clinics, Ambulatory Surgical Centers, Casualty Care Center, And Others), and South Korea Hemostats Market Insights, Industry Trend, Forecasts to 2035

South Korea Hemostats Market Insights Forecasts to 2035

• The South Korea Hemostats Market Size Was Estimated at USD 69.2 Million in 2024
• The Market Size is Expected to Grow at a CAGR of around 7.22% from 2025 to 2035
• The South Korea Hemostats Market Size is Expected to Reach USD 149.0 Million by 2035

According to a Research Report Published by Spherical Insights & Consulting, The South Korea Hemostats Market Size is anticipated to Reach USD 149.0 Million by 2035, Growing at a CAGR of 7.22% from 2025 to 2035. The need for hemostats to control bleeding during complex surgeries has increased due to the rising incidence of chronic illnesses and the rise in the number of surgical procedures.

Market Overview

The industry devoted to the creation, production, and distribution of tools and substances used to stop bleeding during surgery and in cases of catastrophic injury is included in the hemostats market. By encouraging blood clotting or mechanically sealing blood arteries, these hemostatic products function. The market offers a broad variety of goods, such as advanced hemostats with biological components, absorbable and non-absorbable materials, and mechanical devices (such as clips and staples). The need for hemostatic drugs is fueled by an increase in surgical procedures performed globally, including both conventional and less invasive procedures.  Hemostats that work well in tiny incisions are required when minimally invasive surgical procedures are used. The market for hemostats is further boosted by the increased frequency of chronic disorders that necessitate surgical intervention due to an aging population. Government funding for medical research and development, including hemostatic technologies, results in new developments and improvements in hemostatic agents, which further propels market expansion.

Report Coverage

This research report categorizes the market for South Korea hemostats market based on various segments and regions forecasts revenue growth, and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the South Korea hemostats market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment South Korea hemostats market.

Driving Factors

The rising number of surgical procedures includes orthopedic, cardiovascular, and trauma surgeries. Increasing incidences of chronic diseases, aging populations, and the growing demand for minimally invasive surgeries also fuel market expansion. Technological advancements in hemostatic agents, improved surgical outcomes, and the need for effective blood loss management further support growth.

Restraining Factors

The high costs of advanced products can burden healthcare budgets, particularly in emerging markets. Complex regulatory approval processes and rigorous clinical trials slow time-to-market. Additionally, the risk of adverse events such as infections or immunogenic reactions can limit adoption. Reimbursement inconsistencies and competition from alternative bleeding-control technologies like surgical sealants and electrocautery further challenge growth.

Market Segmentation

The South Korea hemostats market share is classified into type, formulation, application, and end-use.

• The oxidized regenerated cellulose-based hemostats segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea hemostats market is segmented by type into oxidized regenerated cellulose-based hemostats and combination haemostats. Among these, the biological aerated biofilter system segment held a significant share in 2024 and is expected to grow at a substantial CAGR during the forecast period.  Its proven effectiveness, biocompatibility, and rapid absorption properties. Its continued growth is driven by increasing surgical procedures, demand for minimally invasive techniques, and strong clinical preference for safe, fast-acting bleeding control solutions.

• The matrix & gel hemostats segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea hemostats market is segmented by formulation into matrix & gel hemostats and sponge hemostats. Among these, the matrix & gel hemostats segment held a significant share in 2024 and is expected to grow at a significant CAGR during the forecast period. Their easy application, rapid action, and effectiveness in controlling bleeding in complex surgical procedures. Their growth is driven by rising demand for minimally invasive surgeries, enhanced surgical outcomes, and increasing adoption in hospitals and clinics.

• The orthopedic surgery segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea hemostats market is segmented by application into orthopedic surgery and cardiovascular surgery. Among these, the orthopedic surgery segment dominated the share in 2024 and is expected to grow at a significant CAGR during the forecast period. The rising incidence of bone injuries, an aging population, and increased demand for joint replacement procedures. The segment’s growth is further driven by advancements in surgical techniques and the need for effective bleeding control in complex orthopedic operations.

• The hospital & clinics segment held the majority of the share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The South Korea hemostats market is segmented by end-use into hospital & clinics, ambulatory surgical centers, casualty care center, and others. Among these, the hospital & clinics segment held the majority of the share in 2024 and is expected to grow at a significant CAGR during the forecast period.  The high volume of surgical procedures, advanced medical infrastructure, and availability of skilled healthcare professionals. Its growth is supported by increasing healthcare investments, improved patient access, and rising adoption of advanced surgical products.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea hemostats market along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborate analysis focusing on the companies' current news and developments, including product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Abbott Korea Limited
• Bard Korea
• Baxter International
• Cardical Health Korea
• Curesys
• DalimTissen
• Green Cross Corp (GC Pharma)
• Hanmi Healthcare
• Hyundai Pharm
• Johnson & Johnson Medical Korea
• Nano Pharm
• SK Plasma Co. Ltd.
• Others

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the South Korea hemostats market based on the below-mentioned segments:

South Korea Hemostats Market, By Type

• Oxidized Regenerated Cellulose-Based Hemostats
• Combination Haemostats

South Korea Hemostats Market, By Formulation

• Matrix & Gel Hemostats
• Sponge Hemostats

South Korea Hemostats Market, By Application

• Orthopedic Surgery
• Cardiovascular Surgery

South Korea Hemostats Market, By end-use

• Hospital & Clinics
• Ambulatory Surgical Centers
•  Casualty Care Center
• Others